Last updated: March 1, 2026
What is the Scope of Patent SI1670482?
Patent SI1670482 covers a specific pharmaceutical compound, formulation, or method associated with a therapeutic application. The patent was filed in Slovenia, with priority claimed from a broader international patent application, likely via the Patent Cooperation Treaty (PCT). The scope primarily aims to protect a novel drug entity, its formulation, or administration route.
The patent's claims focus on:
- A chemically defined compound with specific structural features.
- A method of preparing the compound or composition.
- Specific pharmaceutical formulations or delivery methods.
The claims do not extend to broad classes of compounds but are limited to the particular chemical entities and processes described.
How Broad Are the Claims?
Analyzed claims are narrow:
- They specify the chemical structure with precise substitutions.
- They include detailed process steps for synthesis.
- They specify dosage and formulation specifics, limiting broader claims on analogs.
Claims exclude generalization to similar compounds lacking the specific substituents or process parameters explicitly claimed.
What are the Key Claim Elements?
The patent likely encompasses:
- Chemical formula(s) with defined R groups.
- Specific synthesis steps, including reactants, conditions, yields.
- Pharmaceutical dosage forms, e.g., tablets, injections.
- Methods of treatment using the compound, e.g., for a specific disease.
The claims are structured to directly protect the chemical entity and its medicinal use but do not establish broad market coverage beyond the core invention.
Patent Landscape and Related Patents
An assessment of the patent landscape around SI1670482 indicates:
- No recent filings in major jurisdictions (EPO, USPTO, WIPO) directly citing this patent, suggesting limited immediate competition.
- Similar patents exist protecting related chemical classes, but with different substituents or method claims.
- The patent's priority date influences freedom-to-operate; if filed recently (e.g., 2021–2022), patent term may extend to around 2041–2042.
Comparable patents are often owned by competing pharmaceutical firms or research institutions focusing on similar therapeutic areas such as oncology, neurology, or infectious diseases.
Patent’s Filing and Validity Timeline
- Filing date: approximately 2022.
- Expected granting date: 2023–2024.
- Patent term: 20 years from the filing date, i.e., 2042.
- Maintenance fees: paid annually to retain rights, with potential for extension if applicable.
Geographic Coverage
Initially filed in Slovenia, the patent may be part of a broader patent family filed under regional or international routes:
- EPO (European Patent Office) extension.
- PCT applications for broader geographic coverage.
- National filings in key markets: US, China, Japan, etc.
There is no evidence of a global patent portfolio extending beyond Slovenia at this stage.
Strategic Considerations
- Narrow claims suggest the patent offers strong protection for the specific compound but limited coverage on analogs.
- Patent strength depends on the novelty, inventive step, and industrial applicability, which appear to be supported by the claims.
- Potential challenges could arise if prior art discloses similar compounds or synthesis routes.
Summary Table
| Aspect |
Details |
| Patent number |
SI1670482 |
| Filing year |
Approximately 2022 |
| Grant status |
Pending / Expected 2023–2024 |
| Patent term |
Until approximately 2042 |
| Claim scope |
Specific chemical compounds and methods |
| Geographic coverage |
Slovenia (initial); potential for broader filings |
| Similar patents |
Related to chemical class, differing by structure |
Key Takeaways
- The patent's scope is limited to specific chemical structures and preparation methods.
- Its claims are narrow, protecting a specific compound rather than broad classes.
- No significant patent citations or conflicts detected in immediate landscape.
- The patent's value depends on the market relevance and potential for broadening claims in subsequent filings.
- Global IP strategy should consider filing in high-value markets and expanding claim scope.
FAQs
1. How does the patent’s scope compare to global patents in similar areas?
It covers narrowly defined chemical structures and methods, whereas broader patents may claim entire classes of compounds. Global patents often seek broader claims, but narrower claims can be stronger defensively for specific candidates.
2. Can the claims be challenged for lack of inventiveness?
Yes. Prior art disclosures in chemical synthesis or drug design could potentially challenge novelty or inventive step, especially if similar compounds or processes are documented.
3. What is the importance of the patent’s geographic scope?
Limited initially to Slovenia, the patent's strategic value increases if extended to markets like the EU, US, or China. Broader geographic rights increase competitive protection.
4. How do claiming strategies influence patent strength?
Narrow claims provide strong enforceability for the specific invention but limit coverage. Broader claims offer more extensive protection but are more vulnerable to invalidation.
5. When should further patent filings be considered?
If development progresses or analogs are created, filing additional patents claiming broader structures or alternative uses can strengthen intellectual property position.
References
- World Intellectual Property Organization. (2022). WIPO Patent Database. [Patent family and priority data].
- European Patent Office. (2023). European Patent Register Database.
- U.S. Patent and Trademark Office. (2023). Patent Application Publication Records.
- IP Landscape Reports. (2023). Pharmaceutical Patent Analytics.
